$ATEX

Anterix Inc.

alphai earnings readFirst Quarter Fiscal Year 2027 · AUG 11Anterix Inc. Reports First Quarter Fiscal Year 2027 ResultsVerdict: mixed

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

0
1
1
$10.4M
Kuhn Thomas R.
0%
See all $ATEX insider activity →
Low

Guttman-McCabe Christopher sold $2.2M of ATEX

Guttman-McCabe Christopher (Chief Reg & Comm Officer) sold 23,439 shares of Anterix Inc. (ATEX) at an average of $92.36 ($90.61–$93.59, $2.16M total) across 4 trades on 2026-08-25.

Anterix (NASDAQ: ATEX) chair sells 10K shares near $91

Anterix (ATEX) Executive Chairman Thomas R. Kuhn exercised 10,000 stock options at $33.62 per share and sold 10,000 shares at an average price of $89, plus 1,654 shares at $79.52 to cover taxes. He also received a grant of 2,791 restricted stock units.

Kuhn Thomas R. sold $1.0M of ATEX

Kuhn Thomas R. sold 11,654 shares of Anterix Inc. (ATEX) at an average of $87.53 ($79.52–$91.01, $1.02M total) across 5 trades over 2026-06-18 to 2026-08-24.

ATEX sentiment & insider activity

Over the past 7 days, alphai's AI scored 2 news stories mentioning ATEX (Anterix Inc.). Coverage has skewed bearish: 0 bullish, 1 neutral, and 1 bearish.

Recent ATEX coverage spans insider activity, earnings and financial news.

In the last 30 days, ATEX insiders filed 13 SEC Form 4 transactions — no purchases and 13 sales ($10.4M). The most active reporter was Kuhn Thomas R. with 4 filings.

What's driving ATEX

alphai scores every news story that mentions ATEX with an AI model for sentiment and relevance, and aggregates insider trades from Anterix Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ATEX

Score
$ATEXMed

Why is Anterix stock surging today?

Anterix (ATEX) stock rose 7.1% to $91.37, driven by Q1 FY2027 earnings and regulatory developments. Spectrum revenue increased to $1.96M, with $116M cash and no debt. Management highlights undervaluation, citing spectrum worth $0.60/MHz-pop vs. $2.50 in auctions. CEO notes growing demand for 900 MHz footprint and successful satellite tests with Lynk Global. Broader market gains were modest, with S&P 500 up 0.3% and Nasdaq up 0.27%.

$ATEXMed

Anterix (ATEX) Q1 2027 Earnings Call Transcript

Anterix (ATEX) reported Q1 2027 revenue of $2M, up from $1.4M YoY, with net income of $240K. Operating expenses decreased to $12.9M. The company has $116M in cash, no debt, and $226.7M left for share repurchases. Management highlighted 12 active deals, spectrum clearing progress, and support for SpaceX's FCC proposal. CFO warned of potential higher costs if spectrum clearing is accelerated.

Wall Street Standouts: 9 Firms That Beat Q2 Earnings Expectations

Insider Monkey highlights nine companies that beat Q2 EPS expectations among 350+ firms reporting by Aug. 11. Reported EPS surprises include RideNow Group (RDNW) $0.16 vs $0.13, Anterix (ATEX) $0.01 vs -$0.17, Super Micro Computer (SMCI) $1.70 vs $0.96, and Fennec Pharmaceuticals (FENC) $0.05 vs $0.01. The rest of the piece shifts to AI themes and promotional content.

$ATEXMed

Anterix Q1 Earnings Call Highlights

Anterix (NASDAQ:ATEX) reported Q1 FY2027 GAAP revenue of $2 million and operating expenses of $9.5 million. Management said it cleared 40% of U.S. counties for 10 MHz broadband after the FCC expanded the band, and expects $10 million in additional contracted proceeds in FY2027. It cited spectrum valuation references of $0.60 per MHz-POP and 85% of MHz-POPs remaining available.

Related tickers